Healthcare Business

XBiotech Stock Crumbles Following Disappointing EMA Meeting

XBiotech Inc. (NASDAQ: XBIT) saw its shares fall sharply after the company issued an update on its recent meeting with the European Medical Agency (EMA). The Oral Explanation meeting dealt ...
Read Full Story »

Why Immune Pharmaceuticals Shares Are Skyrocketing

Shares of Immune Pharmaceuticals Inc. (NASDAQ: IMNP) saw an incredible gain in Thursday’s session following a key announcement. The company says that it has entered into a letter of intent ...
Read Full Story »

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Shares of Edge Therapeutics Inc. (NASDAQ: EDGE) posted a solid gain in Wednesday’s trading session after the company announced that it would be conducting a registered direct offering of its common ...
Read Full Story »

Audentes Therapeutics Gears Up for Secondary Offering

Audentes Therapeutics Inc. (NASDAQ: BOLD) saw its shares drop early on Wednesday after the company announced the pricing of its secondary offering. The company said that it intends to price ...
Read Full Story »

Why One Analyst Is Growing Very Bullish on Life Sciences

Over the past five, 10 and 20 years, the life sciences and bioproduction segments have tended to outperform the S&P 500 more often than not. Considering the exposure to biopharma ...
Read Full Story »

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw its shares drop sharply on Tuesday after the company announced a secondary offering. Arena plans to offer 60 million shares of its common stock ...
Read Full Story »

Why Johnson & Johnson Raised Guidance After Missing Sales Estimates

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2017 results before markets opened on Tuesday. The health care giant reported adjusted diluted earnings per share (EPS) of $1.83 on revenue of ...
Read Full Story »

How Dumping ACA Exchanges Boosted UnitedHealth’s Profits

UnitedHealth Group Inc. (NYSE: UNH) reported first-quarter 2017 results before markets opened on Tuesday. The health insurance and benefits management firm reported adjusted diluted quarterly earnings per share (EPS) of ...
Read Full Story »

Why HCA Holdings Stock Tumbled Monday

Health care services provider HCA Holdings Inc. (NYSE: HCA) revealed Monday morning its preliminary financial and operating results for the first quarter of 2017. The report sent the share price ...
Read Full Story »

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

One thing that crept on the radar screen last week is that after eight years of a bull market, five of which are of the secular variety, after the S&P 500 ...
Read Full Story »

Sorrento Therapeutics Gears Up for Secondary Offering

Sorrento Therapeutics Inc. (NASDAQ: SRNE) saw its shares plunge on Thursday after the company announced a secondary offering. The company has yet to disclose how many shares it plans to offer. ...
Read Full Story »

Neurocrine Biosciences Wins Big With FDA Approval

Neurocrine Biosciences Inc. (NASDAQ: NBIX) saw its shares jump after the company reported a key U.S. Food and Drug Administration (FDA) approval. Specifically, the agency approved Ingrezza (valbenazine) capsules for ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, March 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »